title: Decreased activity of clotting factor V during ALL consolidation treatment with mercaptopurine in a child.
authors.forename: Claire
authors.initials: C
authors.lastname: Vignand
authors.forename: Gérard
authors.initials: G
authors.lastname: Couillault
authors.forename: Genevieve
authors.initials: G
authors.lastname: Jolimoy
authors.forename: Fabienne
authors.initials: F
authors.lastname: Dutrillaux
authors.forename: Catherine
authors.initials: C
authors.lastname: Sgro
mesh_terms: D002648:Child; D005165:Factor V / Q000037:antagonists & inhibitors / Q000378:metabolism*; D006801:Humans; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood* / Q000188:drug therapy; D013997:Time Factors
chemical_list: D005165:Factor V; D015122:Mercaptopurine